基于单向快速吸收纤维的膨胀凝固基托桑织物,用于快速控制出血
Junfeng Yang1, Tingting Wan1, Kaidan Yang2
1State Key Laboratory of New Textile Materials and Advanced Processing Technologies, Wuhan Textile University, Wuhan 430073, People's Republic of China.
International journal of biological macromolecules
|June 7, 2024
概括
新的基托桑织物迅速吸收血液,集中血小板和红细胞以加速凝血. 它们独特的结构密封伤口,与传统布相比,提供更好的出血控制.
科学领域:
- 生物材料科学 生物材料科学
- 织工程 织工程 织工程
- 血液静止研究 血液静止研究
背景情况:
- 有效的血液静止对于控制出血至关重要.
- 血红细胞和血小板等血液成分的快速缩促进了血块的形成.
- 现有的静血材料往往需要提高吸收,密封和粘附性能.
研究的目的:
- 设计和制造新的扩张凝固酸盐织物,以提高血静.
- 研究这些织物促进血块形成和伤口密封的作用机制.
- 在体内评估开发的酸盐织物的静血性能.
主要方法:
- 使用聚乳酸 (PLA) 芯和碳氧乙基 (CECS) 盖,通过环制造制造核心线.
- 编织PLA@CECS线,制成膨胀凝结性织物.
- 评估织物性能,包括吸水性,孔密封性,机械强度和组织粘附性.
- 在子肝脏,脏和大腿动脉穿孔模型中静血疗效的体内评估.
主要成果:
- 由于CECS纤维,PLA@CECS织物表现出快速的单向吸水.
- 织物的多孔,循环结构在吸水后扩大,有效地封闭毛孔和缩血液成分.
- 这些织物表现出良好的机械性能,抗透能力和湿组织粘附性.
- 在子受伤模型中,与布组相比,观察到更优异的静血性能.
结论:
- 开发的膨胀凝固酸盐织物显示出作为先进的静血材料的巨大潜力.
- 快速吸收,孔隙密封扩张和机械完整性的独特组合增强了出血控制.
- 这些织物提供了一个有前途的替代方案,用于在危急情况下有效管理出血.
相关概念视频
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Coagulation
6.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.2K


